GlassScriptPhysician profile
Ann R Heller
NPI 1851540660
$1,038.78
in general payments reported to CMS, 2019-2025
13 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.61 · 2022: $86.42 · 2023: $119 · 2024: $439 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716 · Consulting Fee: $150 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.76 |
| Consulting Fee | $150.00 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $184.09 | 2022-2025 | |
| Harmony Biosciences LLC | $183.91 | 2021-2025 | Wakix |
| Amgen INC. | $149.51 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $118.14 | 2024-2025 | Tezspire |
| Axsome Therapeutics, INC. | $95.22 | 2023-2025 | Sunosi |
| Inspire Medical Systems, INC. | $78.44 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $56.30 | 2024-2025 | Dupixent |
| Insmed, INC. | $54.72 | 2024 | Arikayce |
| Glaxosmithkline, LLC. | $37.73 | 2023-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Verona Pharma, INC. | $27.18 | 2025 | Ohtuvayre |
| Electromed, INC. | $20.23 | 2024 | Smartvest |
| Daiichi Sankyo INC. | $19.64 | 2022 | |
| Genzyme Corporation | $13.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Heller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.